Related Experiment Videos
Capromab Pendetide immunoscintigraphy: connecting the dots for prostate cancer imaging
Cancer Biotherapy & Radiopharmaceuticals
|May 10, 2000
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
An evolving approach to the surgical management of superficial bladder carcinoma.
Surgical technology international·2011
Preneoplastic lesions of the prostate-clinical, pathological and molecular biological aspects.
In vivo (Athens, Greece)·2002
Lactylation Signatures as Predictors of Prognosis and Therapeutic Response in Lung Adenocarcinoma: Implications for Ultrasound-Based Therapeutic Strategies.
Cancer biotherapy & radiopharmaceuticals·2026
PWidFHNet: Parallel Wider Forward Harmonic Net to Classify Breast Cancer Using Histopathological Images.
Cancer biotherapy & radiopharmaceuticals·2026
Prognostic Factor Analysis and Nomogram Development in Castration-Resistant Prostate Cancer with Visceral Metastases for Future Radionuclide Therapy Selection.
Cancer biotherapy & radiopharmaceuticals·2026
Development of a 177Lu-Labeled Glypican-3-Targeted Antibody Radiopharmaceutical for Adjuvant Radionuclide Therapy Following Hepatocellular Carcinoma Resection.
Cancer biotherapy & radiopharmaceuticals·2026
Synergistic Mechanisms and Clinical Progress of Radionuclide Therapy Combined with Immune Checkpoint Inhibitors in Colorectal Cancer.
Cancer biotherapy & radiopharmaceuticals·2026
Personalized Radionuclide Therapy via Avidin-Biotin Pretargeting: Biodistribution and Dosimetry of 177Lu-DOTA-biotin with AvidinOX™ in Solid Tumors.
Cancer biotherapy & radiopharmaceuticals·2026
The prevalence of isthmic and degenerative lumbar spondylolisthesis: an analysis of 1376 patients.
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia·2026
Distinguishing enhancing from non-enhancing hyperdense adnexal lesions with spectral reconstructions at photon counting CT.
Abdominal radiology (New York)·2026